Lo­cus pulls in a mod­est Se­ries B as it at­tempts to em­u­late on­col­o­gy's pre­ci­sion med­i­cine mod­el in an­tibac­te­ri­als

De­spite a sig­nif­i­cant bear mar­ket af­fect­ing the pub­lic biotech sec­tor, pri­vate com­pa­nies are still man­ag­ing to pull in VC-backed fund­ing rounds. The lat­est such round …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER